SDS Biotech K.K. reported consolidated earnings results for the nine months ended September 30, 2014. For the nine months, on consolidated basis, the company reported net sales of ¥10,011 million against ¥7,769 million a year ago. Operating income was ¥555 million against ¥249 million a year ago. Ordinary income was ¥409 million against ¥160 million a year ago. Net income was ¥220 million or ¥28.19 per share against ¥112 million or ¥14.37 per share a year ago. Net assets per share as of September 30, 2014 were ¥616.17 per share compared to ¥592.99 per share, at the end of December 31, 2013. Income before income taxes and minority interests was ¥402,273,000 against ¥160,002,000 a year ago.

The company provided consolidated earnings guidance for the full year ending December 31, 2014. For the year, the company expects to report net sales of ¥14,866 million, operating income of ¥1,352 million, ordinary income of ¥1,179 million and net income of ¥684 million or ¥87.35 per share.

The company also provided dividend guidance for the full year ending December 31, 2014. For the year, the company expects year end dividend of JPY 10.00 per share. The company paid year end dividend of JPY 10.00 per share for the year ended March 31, 2013.